FDA NDC Directory · JSON-LD · Markdown

Caspofungin Acetate

NDC 63323-356 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA206110
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsCASPOFUNGIN ACETATE (5 mg/mL)
Marketing started20161230
Package count1

External sources

Source: openFDA. Public-domain (CC0).